We are live on ! Find out more
DGM

Darwin Global Management Portfolio holdings

AUM $3.77B
1-Year Est. Return 307.72%
This Fund
S&P 500
This Quarter Est. Return
+63.31%
1 Year Est. Return
+307.72%
3 Year Est. Return
+2,873.14%
5 Year Est. Return
+48,315.58%
10 Year Est. Return
–
AUM
$612M
AUM Growth
+$246M
Cap. Flow
+$31.4M
Cap. Flow %
5.13%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
AMAM
Ambrx Biopharma Inc
AMAM
+$67.7M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$30.3M
2
ARGX icon
argenx
ARGX
+$4.66M
3
KROS icon
Keros Therapeutics
KROS
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAM
1
DELISTED
Ambrx Biopharma Inc
AMAM
$275M 44.91%
16,688,636
+5,384,063
+48% +$67.7M
TGTX icon
2
TG Therapeutics
TGTX
$8.4B
$230M 37.68%
9,278,439
-1,172,802
-11% -$30.3M
ARGX icon
3
argenx
ARGX
$53.8B
$107M 17.42%
273,343
-11,855
-4% -$4.66M
KROS icon
4
Keros Therapeutics
KROS
$211M
– –
-31,386
Closed -$1.34M

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
ABC
Associated Banc-Corp Green Bay, Wisconsin $3.78B AUM 21.74% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.76B AUM 26.04% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return

Darwin Global Management's Q2 2023 Portfolio in Review

As of Q2 2023, Darwin Global Management held 4 positions worth $612M, up 67% from $366M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Darwin Global Management deployed $31.4M of net new capital in Q2 2023, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was TG Therapeutics, an estimated $30.3M trimmed.

  • Darwin Global Management added most to Ambrx Biopharma Inc in Q2 2023, an estimated $67.7M increase.
  • Darwin Global Management's biggest Q2 2023 reduction was TG Therapeutics, cutting an estimated $30.3M.
  • Darwin Global Management fully exited Keros Therapeutics in Q2 2023, selling an estimated $1.34M.
  • Darwin Global Management's ten largest holdings make up 100% of its $612M portfolio in Q2 2023.
  • Darwin Global Management opened 0 new positions and closed 1 in Q2 2023.
  • Darwin Global Management's portfolio value rose 67% quarter-over-quarter to $612M.

Based on Darwin Global Management's 13F filing for Q2 2023, filed 14 Aug 2023.